BCYC
Price
$8.75
Change
+$0.71 (+8.83%)
Updated
Jul 18, 01:45 PM (EDT)
Capitalization
556.8M
13 days until earnings call
IMTX
Price
$6.06
Change
-$0.15 (-2.42%)
Updated
Jul 18, 01:52 PM (EDT)
Capitalization
754.83M
25 days until earnings call
Interact to see
Advertisement

BCYC vs IMTX

Header iconBCYC vs IMTX Comparison
Open Charts BCYC vs IMTXBanner chart's image
Bicycle Therapeutics
Price$8.75
Change+$0.71 (+8.83%)
Volume$4.73K
Capitalization556.8M
Immatics
Price$6.06
Change-$0.15 (-2.42%)
Volume$100
Capitalization754.83M
BCYC vs IMTX Comparison Chart in %
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. IMTX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (BCYC: $8.04 vs. IMTX: $6.21)
Brand notoriety: BCYC and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 120% vs. IMTX: 35%
Market capitalization -- BCYC: $556.8M vs. IMTX: $754.83M
BCYC [@Biotechnology] is valued at $556.8M. IMTX’s [@Biotechnology] market capitalization is $754.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMTX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while IMTX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 5 bearish.
  • IMTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -0.62% price change this week, while IMTX (@Biotechnology) price change was +3.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.34%. For the same industry, the average monthly price growth was +13.98%, and the average quarterly price growth was +35.38%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 30, 2025.

IMTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($755M) has a higher market cap than BCYC($557M). IMTX YTD gains are higher at: -12.658 vs. BCYC (-42.571). IMTX has higher annual earnings (EBITDA): -4.49M vs. BCYC (-200.61M). BCYC has more cash in the bank: 793M vs. IMTX (544M). BCYC has less debt than IMTX: BCYC (8.33M) vs IMTX (18.4M). IMTX has higher revenues than BCYC: IMTX (144M) vs BCYC (25.7M).
BCYCIMTXBCYC / IMTX
Capitalization557M755M74%
EBITDA-200.61M-4.49M4,469%
Gain YTD-42.571-12.658336%
P/E RatioN/A27.61-
Revenue25.7M144M18%
Total Cash793M544M146%
Total Debt8.33M18.4M45%
FUNDAMENTALS RATINGS
BCYC vs IMTX: Fundamental Ratings
BCYC
IMTX
OUTLOOK RATING
1..100
1513
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9690
PRICE GROWTH RATING
1..100
6549
P/E GROWTH RATING
1..100
10064
SEASONALITY SCORE
1..100
1932

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (20) in the null industry is somewhat better than the same rating for IMTX (61). This means that BCYC’s stock grew somewhat faster than IMTX’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as IMTX (100). This means that BCYC’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (90) in the null industry is in the same range as BCYC (96). This means that IMTX’s stock grew similarly to BCYC’s over the last 12 months.

IMTX's Price Growth Rating (49) in the null industry is in the same range as BCYC (65). This means that IMTX’s stock grew similarly to BCYC’s over the last 12 months.

IMTX's P/E Growth Rating (64) in the null industry is somewhat better than the same rating for BCYC (100). This means that IMTX’s stock grew somewhat faster than BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCIMTX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 19 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX19.00N/A
N/A
Saratoga Health & Biotechnology A
RAGTX69.09N/A
N/A
Virtus Zevenbergen Technology A
MGFRX9.48N/A
N/A
MassMutual Global R4
ASERX116.25N/A
N/A
American Century Select R
IPESX5.28N/A
N/A
Voya Large Cap Value Port S

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+3.34%
XNCR - BCYC
54%
Loosely correlated
+2.72%
RPTX - BCYC
51%
Loosely correlated
+6.29%
RLAY - BCYC
50%
Loosely correlated
+0.27%
INO - BCYC
48%
Loosely correlated
+2.24%
RCUS - BCYC
45%
Loosely correlated
+1.73%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with OCUL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+1.31%
OCUL - IMTX
50%
Loosely correlated
+1.16%
IDYA - IMTX
49%
Loosely correlated
-0.27%
RGNX - IMTX
48%
Loosely correlated
+2.24%
CRNX - IMTX
48%
Loosely correlated
+3.51%
DAWN - IMTX
48%
Loosely correlated
-1.81%
More